Cargando…
Systemic administration of bone marrow‐derived cells leads to better uterine engraftment than use of uterine‐derived cells or local injection
Stem cells are recruited to the uterus where they differentiate into endometrial cells and have been suggested as potential therapy for uterine injury such as Asherman's syndrome. However, it is unknown whether local intrauterine injection may result in better stem cell engraftment of the uteru...
Autores principales: | Liu, Ying, Tal, Reshef, Pluchino, Nicola, Mamillapalli, Ramanaiah, Taylor, Hugh S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742714/ https://www.ncbi.nlm.nih.gov/pubmed/28782281 http://dx.doi.org/10.1111/jcmm.13294 |
Ejemplares similares
-
Therapeutic role of uterine-derived stem cells in acute kidney injury
por: Mamillapalli, Ramanaiah, et al.
Publicado: (2022) -
CXCR4 or CXCR7 antagonists treat endometriosis by reducing bone marrow cell trafficking
por: Pluchino, Nicola, et al.
Publicado: (2020) -
CXCL12 Promotes Stem Cell Recruitment and Uterine Repair after Injury in Asherman’s Syndrome
por: Sahin Ersoy, Gulcin, et al.
Publicado: (2017) -
Chemoattraction of bone marrow-derived stem cells towards human endometrial stromal cells is mediated by estradiol regulated CXCL12 and CXCR4 expression
por: Wang, Xiuli, et al.
Publicado: (2015) -
Adult bone marrow progenitors become decidual cells and contribute to embryo implantation and pregnancy
por: Tal, Reshef, et al.
Publicado: (2019)